Last reviewed 2026-04-19 · How we verify

COVID vaccination

At a glance

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

• Myocardial Injury and Outcomes Following COVID-19 Vaccination (MYOVAX Study) (NA)
• Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals (PHASE2, PHASE3)
• Influenza Vaccination, ACEI and ARB in the Evolution of SARS-CoV2 Infection
• Evaluation of Full Versus Fractional Dose of COVID-19 Vaccine Given as a Booster for the Prevention of COVID-19 in Adults in Mongolia. (PHASE3)
• Effectiveness of mRNA-1273 Variant-Containing Vaccine Formulation Against Severe Outcomes in Adults Aged 50-64 Years Without Risk Factors for Severe COVID-19 (PHASE4)
• Use and Effectiveness of COVID-19 Vaccines Using State Vaccine Registries and Insurance Claims Data
• Safety and Immunogenicity of a Booster Vaccination With an Adapted Vaccine (PHASE2, PHASE3)
• Immunogenicity and Safety of a Booster Vaccination With a Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Healthy Adults Volunteers Fully Vaccinated Followed by an Extension Period to Study a Fourth Dose Administration. (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.